The absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3
Abstract Mesodiencephalic dopamine neurons (mdDA) of the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) play critical roles in regulating movement and motivation. Pitx3 is an essential transcription factor required for proper embryonic development and terminal differentiation...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07552-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850207434381983744 |
|---|---|
| author | Willemieke M. Kouwenhoven Edward J. Robinson Daniek Hamberg Lars von Oerthel Marten P. Smidt Lars P. van der Heide |
| author_facet | Willemieke M. Kouwenhoven Edward J. Robinson Daniek Hamberg Lars von Oerthel Marten P. Smidt Lars P. van der Heide |
| author_sort | Willemieke M. Kouwenhoven |
| collection | DOAJ |
| description | Abstract Mesodiencephalic dopamine neurons (mdDA) of the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) play critical roles in regulating movement and motivation. Pitx3 is an essential transcription factor required for proper embryonic development and terminal differentiation of mdDA neurons. Although Pitx3 is expressed in every mdDA neuron, its ablation results only in the absence of the SNc, not the VTA. The developmental stage at which the loss of SNc first becomes apparent, as well as the underlying mechanism, remains elusive. Here, we demonstrate, using a Pitx3 knockout GFP knock-in mouse model, that this loss does not occur during embryogenesis but rather postnatally. Quantification of GFP expression revealed a significant reduction in the total number of dopamine neurons at postnatal day 3, but not at embryonic day 14.5, 15.5, and 18.5. Mechanistically this reduction is accompanied by an increase in the number of cleaved caspase 3-positive GFP neurons, suggesting apoptosis. In addition, RT-PCR performed on isolated GFP neurons, one day before the loss of dopamine neurons revealed a notable elevation in the expression of the pro-apoptotic BH3-only factor Noxa. Overexpression of Noxa in dopaminergic MN9D cells dose-dependently increases the level of cleaved caspase 3 and the number of propidium iodide-positive cells, indicating that Noxa expression is sufficient to induce cell death in dopamine cells. Additionally, Noxa expression in MN9D cells, combined with a Bax-inhibiting peptide, reduces the number of cleaved caspase 3-positive and propidium iodide-positive cells, further supporting apoptosis as the mechanistic form of cell death. Overall, our study provides insights into the cell death machinery implicated in the loss of dopamine neurons, which may hold relevance for diseases affected by the loss of dopamine neurons such as Parkinson’s disease, where this is a hallmark feature. |
| format | Article |
| id | doaj-art-88f2d6bbacd64f0da01cb82d62e09576 |
| institution | OA Journals |
| issn | 2041-4889 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj-art-88f2d6bbacd64f0da01cb82d62e095762025-08-20T02:10:31ZengNature Publishing GroupCell Death and Disease2041-48892025-04-0116111110.1038/s41419-025-07552-wThe absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3Willemieke M. Kouwenhoven0Edward J. Robinson1Daniek Hamberg2Lars von Oerthel3Marten P. Smidt4Lars P. van der Heide5Swammerdam Institute for Life Sciences, Molecular Neuroscience Lab, University of AmsterdamSwammerdam Institute for Life Sciences, Molecular Neuroscience Lab, University of AmsterdamSwammerdam Institute for Life Sciences, Molecular Neuroscience Lab, University of AmsterdamSwammerdam Institute for Life Sciences, Molecular Neuroscience Lab, University of AmsterdamSwammerdam Institute for Life Sciences, Molecular Neuroscience Lab, University of AmsterdamSwammerdam Institute for Life Sciences, Molecular Neuroscience Lab, University of AmsterdamAbstract Mesodiencephalic dopamine neurons (mdDA) of the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) play critical roles in regulating movement and motivation. Pitx3 is an essential transcription factor required for proper embryonic development and terminal differentiation of mdDA neurons. Although Pitx3 is expressed in every mdDA neuron, its ablation results only in the absence of the SNc, not the VTA. The developmental stage at which the loss of SNc first becomes apparent, as well as the underlying mechanism, remains elusive. Here, we demonstrate, using a Pitx3 knockout GFP knock-in mouse model, that this loss does not occur during embryogenesis but rather postnatally. Quantification of GFP expression revealed a significant reduction in the total number of dopamine neurons at postnatal day 3, but not at embryonic day 14.5, 15.5, and 18.5. Mechanistically this reduction is accompanied by an increase in the number of cleaved caspase 3-positive GFP neurons, suggesting apoptosis. In addition, RT-PCR performed on isolated GFP neurons, one day before the loss of dopamine neurons revealed a notable elevation in the expression of the pro-apoptotic BH3-only factor Noxa. Overexpression of Noxa in dopaminergic MN9D cells dose-dependently increases the level of cleaved caspase 3 and the number of propidium iodide-positive cells, indicating that Noxa expression is sufficient to induce cell death in dopamine cells. Additionally, Noxa expression in MN9D cells, combined with a Bax-inhibiting peptide, reduces the number of cleaved caspase 3-positive and propidium iodide-positive cells, further supporting apoptosis as the mechanistic form of cell death. Overall, our study provides insights into the cell death machinery implicated in the loss of dopamine neurons, which may hold relevance for diseases affected by the loss of dopamine neurons such as Parkinson’s disease, where this is a hallmark feature.https://doi.org/10.1038/s41419-025-07552-w |
| spellingShingle | Willemieke M. Kouwenhoven Edward J. Robinson Daniek Hamberg Lars von Oerthel Marten P. Smidt Lars P. van der Heide The absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3 Cell Death and Disease |
| title | The absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3 |
| title_full | The absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3 |
| title_fullStr | The absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3 |
| title_full_unstemmed | The absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3 |
| title_short | The absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3 |
| title_sort | absence of pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro apoptotic bcl2 factor noxa and cleaved caspase 3 |
| url | https://doi.org/10.1038/s41419-025-07552-w |
| work_keys_str_mv | AT willemiekemkouwenhoven theabsenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT edwardjrobinson theabsenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT daniekhamberg theabsenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT larsvonoerthel theabsenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT martenpsmidt theabsenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT larspvanderheide theabsenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT willemiekemkouwenhoven absenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT edwardjrobinson absenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT daniekhamberg absenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT larsvonoerthel absenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT martenpsmidt absenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 AT larspvanderheide absenceofpitx3resultsinpostnatallossofdopamineneuronsandisassociatedwithanincreaseintheproapoptoticbcl2factornoxaandcleavedcaspase3 |